Overview:

Stroke is predominantly observed among the geriatric population and is globally considered as a major cause of death. The rise in adoption of unhealthy lifestyle patterns, alcohol and smoking addiction has collectively contributed to the rise in prevalence of stroke.  As per the America Medical Association, around 40% of geriatric population (aged 55 and above) of U.S. suffer from stroke. The World Health Organization estimates around 17 million deaths due to stroke annually. According to the Centers for Disease Control and Prevention, around 0.7 million individuals in the U.S. suffer from stroke each year. The rise in prevalence of stroke fuels the overall market growth. The stroke management market is analysed by segmenting the market into type of products, application and geography. The products are further classified into diagnostic and therapeutic products.

The growing awareness among individuals and healthcare professionals play an important role in the growth of this market. The rise in awareness has led to the increase in diagnosis rate of stroke, thus accounted for its maximum market share in 2017. With the rise in technological advancements and with patients considering preventive diagnosis, the diagnostic segment would also attain fastest CAGR during the forecast period. The availability of suitable treatment guidelines ensures appropriate treatment thus catalysing the overall stroke management market. The American Heart Association collaborated with the Heart Rhythm Society, the American Academy of Family Physicians and the International Society for Heart & Lung Transplantation to develop guidelines that would aid physicians in appropriate treatment of heart failures. These guidelines provide a foundation for appropriate cardiovascular care. However, high treatment cost and stringent government policies to approve new an advanced diagnostic technologies could intervene with the growth of this market.

Of the various geographical regions analysed, North America held the largest market share in 2017. Asia Pacific projected to grow with fastest CAGR during the forecast period from 2018 to 2026. The North American market growth is predominantly driven by the rise in prevalence of chronic diseases leading to cardiovascular risks, increased disposable income, rise in healthcare expenditure and the constant investments in research and development.

The Global Stroke Management Market is segmented as follows:

• By Product
  • Diagnostics
    • Computed Tomography Scan (CT Scan)
    • Magnetic Resonance Imaging (MRI)
    • Carotid Ultrasound
    • Cerebral Angiography
    • Electrocardiography
    • Echocardiography
    • Other diagnostics
  • Therapeutics
    • Tissue Plasminogen Activator
    • Anticoagulant
    • Antiplatelet
    • Antihypertensive
• By Application
  • Ischemic Stroke
  • Haemorrhagic Stroke
• By Geography
  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Rest of Middle East & Africa

The global stroke management market comprises market players namely, , B Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corp, Medtronic Plc., Bristol-Myers Squibb, Cardinal Health, , Siemens Healthcare, GE Healthcare, Merck & Company and GlaxoSmithKline Plc.

This report offers:

• A complete understanding of global stroke management market
• Market estimations and insights for the period from 2016 to 2026, with 2016 as the historical year and 2017 as the base year
• CAGR for the period from 2018 to 2026 with regards to whole market and each segment considered have been incorporated in this report
• Qualitative information of the market dynamic factors such as market drivers, challenges and opportunities
• An elaborative study on the competitive landscape and profiling of the key industrial leaders